Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Interius BioTherapeutics
Novel methods for in vivo cell-specific gene delivery
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
CEO
Phil Johnson
0
Legal Name
Interius BioTherapeutics, Inc.
Company Operating Status
Active
Competitors
Aimmune Therapeutics
Amicus Therapeutics
TARIS Biomedical
Country
United States
0
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@interiusbio.com
0
Founded Date
2019
Founder
Bruce A. Peacock
0
Saar Gill
0
Full Address
3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia, PA 19146
0
Industry
CAR T-Cell therapy
Biomedical engineering
Therapeutics
Biopharmaceutical
Cell therapy
Technology
Immunotherapy
Biology
Biotechnology
Regenerative medicine
•••
Investors
Logos Capital
0
Bruce A. Peacock
Cormorant Asset Management
Fairmount Funds Management
Agent Capital
Longwood Fund
0
Latest Funding Round Date
May 18, 2021
Latest Funding Round Amount (USD)
76,000,000
Latest Funding Type
Series A
LinkedIn URL
@company/interius-biotherapeutics/about
Location
Philadelphia
0
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Phone Number
+16106394644
+12156089333
0
Pitchbook URL
pitchbook.com/profiles...433763-65
Total Funding Amount (USD)
81,500,000
Official Website
interiusbio.com
Find more companies like Interius BioTherapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE